Home › NDC Lookup › Ingredients › Olopatadine Hydrochloride › 00536-1307-23
👁️image loading
(from DailyMed)

Olopatadine Hydrochloride 2 mg/mL Solution/ Drops, 1 bottle — NDC 0536-1307-23 (Billing 00536-1307-23)

by Rugby Laboratories · 1 BOTTLE, PLASTIC in 1 CARTON / 2.5 mL in 1 BOTTLE, PLASTIC

This is a package of 1 bottle of Olopatadine Hydrochloride 2 mg/mL Solution/ Drops from Rugby Laboratories, marketed since Jan 2021 and currently FDA-listed; retail pharmacies pay about $2.96 per mL (NADAC). It is this product's only package size.

NDC 00536-1307-23
🏷️ FDA NDC (as labeled) 0536-1307-23 billing pads the labeler segment with a zero
OTC Generic On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 0536-1307-23 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
0536 labeler · 1307 product · 23 package
Package marketed since
Jan 15, 2021
Sample package
No — commercial package
Listing certified through
Dec 31, 2027
Barcode (UPC-A, from the NDC)
3 0536130723 3
Medicaid fills, this package
71,262 prescriptions in the last four reported quarters
FDA record last changed
Jul 24, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 0536-1307-23
Product NDC 0536-1307
11-digit billing NDC 00536130723
NCPDP billing unit ML — per mL (volume)
RxCUI 1111343
UNII 2XG66W44KF
Application # ANDA209752
SPL Set ID 95424539-7883-2da3-8a46-3d1a19259e15
Established class (EPC) Histamine-1 Receptor Antagonist; Histamine-1 Receptor Inhibitor; Mast Cell Stabilizer
Mechanism of action Histamine H1 Receptor Antagonists
Physiologic effect Decreased Histamine Release
DEA schedule Non-controlled
Marketing category ANDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2021-01-15
Route OPHTHALMIC
Dosage form SOLUTION/ DROPS
Substance OLOPATADINE HYDROCHLORIDE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 86802065102030
GPI class Olopatadine HCl
GCN Seq No 062065
GCN 97848
HICL code 012815
Ingredient (HICL) Olopatadine Hcl
HIC1 code Q
Therapeutic class — broad (HIC1) Ear/Eye/Nose/Rectum/Topical/Vagina/Other
HIC2 code Q6
Therapeutic class — intermediate (HIC2) Ophthalmic Preparations
HIC3 code Q6R
Therapeutic class — specific (HIC3) Eye Antihistamines
AHFS code 52:02.00.00
AHFS class Antiallergic Agents
FDB label name OLOPATADINE HCL 0.2% EYE DROP
FDB brand name Olopatadine Hcl
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 062065
  • GCN: 97848
  • GPI-14 (Medi-Span): 86802065102030
  • HICL (First Databank): 012815
  • AHFS class code: 52:02.00.00
  • RxCUI (RxNorm): 1111343
Why two NDCs? The FDA registers this code as 0536-1307-23 — a 4-4-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the labeler segment → 00536-1307-23. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Histamine-1 Receptor Inhibitor class.

Pharmacologic class Histamine-1 Receptor Inhibitor, Histamine-1 Receptor Antagonist, Mast Cell Stabilizer
Drug family (ATC) Antiallergic agents, excl. corticosteroids, Other antiallergics
How it works Histamine H1 Receptor Antagonists
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name OLOPATADINE HCL 0.2% EYE DROP Ingredient Olopatadine Hcl
📖 What it is MedlinePlus · NLM

Prescription ophthalmic olopatadine (Pazeo) and nonprescription ophthalmic olopatadine (Pataday) are used to relieve itchy eyes caused by allergic reactions to pollen, ragweed, grass, animal hair, or pet dander. Olopatadine is in a class of medications called mast cell stabilizers. It works by preventing the release of substances that cause eye itching.

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • The eye drops relieve itchy eyes from allergies, and some products relieve redness too. The nasal spray relieves seasonal allergic rhinitis symptoms in adults and children 6 and ol...
  • It depends on the product. Some eye drops are twice daily, 6 to 8 hours apart, and others once daily. The nasal spray is twice daily. Follow your label or prescriber.
  • Take your lenses out before using the drops and wait at least 10 minutes before putting them back. Don't wear lenses if your eyes are red. These drops aren't for contact lens irrit...
  • With the nasal spray, a bitter taste, headache, nosebleeds and sore throat are common. It can also make you drowsy, so be careful driving and skip alcohol.
📖 Read our full Olopatadine guide →

Supplement & herbal interactions

Some supplements/herbs that may interact with Olopatadine Hydrochloride — tap one for details:

Dimethylsulfoxide (dmso)Moderate Turpentine OilModerate AlchemillaMinor
🌿 Every supplement checked against Olopatadine Hydrochloride (3 interactions) — ranked by severity →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly $2.964 $7.41 / 2.5 ml
Medicaid paysCMS SDUD · 12 mo $6.36 $15.90 / 2.5 ml
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per mL) — tap or hover for the price & month
Jan 2022 Aug 2022 Jan 2026 Sep 2026 $4.013 $2.822
▼ Down 26% over the last 24 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
00536-1307-23 You're viewing this Main listing 1 BOTTLE, PLASTIC in 1 CARTON / 2.5 mL in 1 BOTTLE, PLASTIC 2021-01-15 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Olopatadine Hydrochloride 2 mg/mL 24208-0617-01 Bausch 1 bottle $1.983 — Availability likely save 33%
Leader Olopatadine Hydrochloride 2 mg/mL 70000-0716-01 CARDINAL 1 bottle $1.983 — Availability likely save 33%
Olopatadine Hydrochloride 2 mg/mLthis 00536-1307-23 Rugby 1 bottle $2.964 — Availability likely —
olopatadine hydrochloride 2 mg/mL 16571-0861-25 Rising 2.5 ml $2.964 — Availability likely —
Olopatadine Hydrochloride Ophthalmic Solution 2 mg/mL 43598-0764-02 Dr. 1 bottle $2.964 — Availability likely —
Olopatadine Hydrochloride 2 mg/mL 46122-0671-27 Amerisource 1 bottle $2.964 — Availability likely —
Olopatadine Hydrochloride 2 mg/mL 68001-0530-69 BluePoint 1 bottle $2.964 — Availability likely —
Olopatadine Hydrochloride 2 mg/mL 68001-0674-92 BluePoint 1 bottle $2.964 — Availability likely —
Olopatadine Hydrochloride 2 mg/mL 70069-0491-01 Somerset 1 bottle $2.964 — Availability likely —
Eye Allergy Itch Relief Once Daily Relief 2 mg/mL 70677-1155-01 Strategic 1 bottle $2.964 — Availability likely —
Olopatadine Hydrochloride Ophthalmic Solution 2 mg/mL 83324-0120-25 Chain 1 bottle $2.964 — Availability likely —
Eye Allergy Itch Relief 2 mg/mL 70000-0053-01 CARDINAL 1 bottle $3.096 — Availability likely +4%
Pataday Once Daily Relief 2 mg/mL 00065-8150-01 Alcon 1 bottle $5.893 — Availability likely +99%
Olopatadine Hydrochloride 2 mg/mL 00363-0869-01 WALGREEN 1 bottle — — FDA listed —
Olopatadine Hydrochloride Ophthalmic Solution 2 mg/mL 00363-7131-25 Walgreens 1 bottle — — FDA listed —
Olopatadine Hydrochloride 2 mg/mL 00363-8022-39 WALGREEN 1 bottle — — FDA listed —
Olopatadine Hydrochloride Ophthalmic Solution 2 mg/mL 11673-0688-25 Target 1 bottle — — FDA listed —
Olopatadine Hydrochloride 2 mg/mL 11822-0063-02 RITE 1 bottle — — FDA listed —
Olopatadine Hydrochloride Ophthalmic Solution 2 mg/mL 11822-9975-02 Rite 1 bottle — — FDA listed —
Olopatadine Hydrochloride Ophthalmic Solution 2 mg/mL 21130-0105-02 Albertsons 1 bottle — — FDA listed —
Olopatadine Hydrochloride 2 mg/mL 24208-0967-01 Bausch 1 bottle — — FDA listed —
Olopatadine Hydrochloride 2 mg/mL 30142-0026-27 Kroger 1 bottle — — FDA listed —
Once Daily Relief 2 mg/mL 37808-0045-25 H 1 bottle — — FDA listed —
Eye Allergy Itch Relief Once Daily Relief 2 mg/mL 43598-0827-02 Dr. 1 bottle — — FDA listed —
Olopatadine Hydrochloride 2 mg/mL 46122-0824-29 AmerisourceBergen 1 bottle — — FDA listed —
Olopatadine Hydrochloride 2 mg/mL 46708-0710-03 Alembic 1 bottle — — FDA listed —
Olopatadine Hydrochloride 2 mg/mL 50090-5613-00 A-S 1 bottle — — FDA listed —
Allergy Relief Eye Drops 2 mg/mL 51316-0675-25 CVS 1 bottle — — FDA listed —
Retaine Allergy 5 mg/2.5mL 54799-0920-25 OCuSOFT 2.5 ml — — FDA listed —
Olopatadine Hydrochloride Ophthalmic Solution Once Daily 2 mg/mL 55910-0137-25 DOLGENCORP, 1 bottle — — FDA listed —
Olopatadine Hydrochloride 2 mg/mL 58602-0007-39 Aurohealth 1 bottle — — FDA listed —
Olopatadine Hydrochloride 2 mg/mL 58602-0010-39 Aurohealth 1 bottle — — FDA listed —
Olopatadine Hydrochloride 2 mg/mL 58602-0013-39 Aurohealth 1 bottle — — FDA listed —
Olopatadine hydrochloride 2 mg/mL 60505-6222-02 Apotex 1 bottle — — FDA listed —
Olopatadine Hydrochloride 2 mg/mL 62332-0502-03 Alembic 1 bottle — — FDA listed —
Olopatadine Hydrochloride 2 mg/mL 62332-0710-03 Alembic 1 bottle — — FDA listed —
Olopatadine Hydrochloride Ophthalmic Solution 2 mg/mL 63868-0821-25 Chain 1 bottle — — FDA listed —
Olopatadine Hydrochloride 2 mg/mL 63941-0024-39 Best 1 bottle — — FDA listed —
Olopatadine Hydrochloride Ophthalmic 2 mg/mL 68083-0231-01 Gland 1 bottle — — FDA listed —
Eye Allergy Itch Relief 2 mg/mL 69168-0495-77 Allegiant 2 bottles — — FDA listed —
CVS Eye Allergy Itch Relief Once Daily 2 mg/mL 69842-0269-25 CVS 1 bottle — — FDA listed —
Olopatadine Hydrochloride 2 mg/mL 72036-0009-39 Harris 1 bottle — — FDA listed —
Olopatadine Hydrochloride 2 mg/mL 72476-0851-21 Retail 1 bottle — — FDA listed —
Olopatadine Hydrochloride 2 mg/mL 72657-0194-11 GLENMARK 2 bottles — — FDA listed —
Olopatadine Hydrochloride 2 mg/mL 73581-0709-02 YYBA 2 bottles — — FDA listed —
Olopatadine Hydrochloride 2 mg/mL 76162-0044-39 TOPCO 1 bottle — — FDA listed —
Olopatadine Hydrochloride 2 mg/mL 79481-1001-02 Meijer 1 bottle — — FDA listed —
Olopatadine Hydrochloride 2 mg/mL 79903-0001-39 Wal-Mart 1 bottle — — FDA listed —
Equate Olopatadine Hydrochloride 2 mg/mL 79903-0318-01 WAL-MART 1 bottle — — FDA listed —
Olopatadine Hydrochloride 2 mg/mL 80539-0001-39 Allwell 1 bottle — — FDA listed —
Olopatadine Hydrochloride Ophthalmic Solution 2 mg/mL 82442-0967-02 TARGET 1 bottle — — FDA listed —
Olopatadine Hydrochloride 2 mg/mL 73581-0712-02 YYBA 2 bottles — — FDA listed —
Olopatadine Hydrochloride 2 mg/mL 73581-0713-02 YYBA 2 bottles — — FDA listed —
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2021
On the market since
Jan 2021
📍
2026
Currently FDA-listed
5 years listed
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

🧪 Avoiding an ingredient? See Olopatadine inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerRugby Laboratories
Application holderGLAND PHARMA LTD
FDA applicationANDA209752 (ANDA)
Labeler code00536
First marketedJan 2021
Product typeHuman Otc Drug
Portfolio149 products on file

More NDCs from Rugby Laboratories labeler code 00536

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 📄 Keep Out of Reach of Children 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 14 words ▾

USE temporarily relieves itchy eyes due to pollen, ragweed, grass, animal hair and dander

⏱️ Dosage and Administration 56 words ▾

DIRECTIONS adults and children 2 years of age and older: put 1 drop in the affected eye(s) once daily, no more than once per day if using other ophthalmic products while using this product, wait at least 5 minutes between each product replace cap after each use children under 2 years of age: consult a doctor

⚠️ Warnings 5 words ▾

WARNINGS For external use only

🧪 Active Ingredient 9 words ▾

ACTIVE INGREDIENT Olopatadine (0.2%) (equivalent to olopatadine hydrochloride 0.222%)

🧪 Inactive Ingredients 22 words ▾

INACTIVE INGREDIENTS Benzalkonium chloride 0.01%, Dibasic sodium phosphate, Edetate disodium, Hydrochloric acid/Sodium hydroxide (adjust pH), Povidone, Sodium chloride, and Water for Injection.

🎯 Purpose 2 words ▾

PURPOSE Antihistamine

📄 Do Not Use 26 words ▾

DO NOT USE if solution changes color or becomes cloudy if you are sensitive to any ingredient in this product to treat contact lens related irritation

📄 When Using This Product 43 words ▾

WHEN USING THIS PRODUCT do not touch tip of container to any surface to avoid contamination remove contact lenses before use wait at least 10 minutes before reinserting contact lenses after use do not wear a contact lens if your eye is red

📄 Stop Use and Ask a Doctor If 27 words ▾

STOP USE AND ASK DOCTOR IF you experience: eye pain changes in vision increased redness of the eye itching worsens or lasts for more than 72 hours

📄 Keep Out of Reach of Children 19 words ▾

KEEP OUT OF REACH OF CHILDREN If swallowed, get medical help or contact a Poison Control Center right away.

📄 Package Label / Principal Display Panel 74 words ▾

PRINCIPAL DISPLAY PANEL NDC 0536-1307-23 Olopatadine HCl Ophthalmic Solution USP, 0.2% antihistamine once daily eye allergy itch relief original prescription strength works in minutes relief from allergens: • pet dander • pollen • grass • ragweed 2.5 mL (0.085 FL OZ) sterile Compare to active ingredient in Pataday Once Daily Relief* Packaged with Tamper-Evident bottle cap. Do Not Use if breakable ring is separated or missing. For Ages 2 and Older 30 DAY SUPPLY

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q4 2025 · 4 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
71.3K
Units reimbursed last 4 qtrs
203K
Gross reimbursed last 4 qtrs
$1.29M
Avg / prescription
$18.11
Avg / unit
$6.3607
Latest quarter Q4 2025
16.5KRx
Medicaid pays / mL
$6.3607
gross reimbursed
vs
NADAC / mL
$2.9636
acquisition cost
=
Spread
+$3.3971
+115% vs cost
What Medicaid paid per mL (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
73% FFS 27% MCO
Fee-for-service · 52,144 Rx Managed care · 19,118 Rx
State Medicaid map
Alaska: 93 units · 12.7 per 100k residents AK Maine: 719 units · 51.5 per 100k residents ME Washington: no data reported WA Idaho: 303 units · 15.4 per 100k residents ID Montana: 205 units · 18.1 per 100k residents MT North Dakota: no data reported ND Minnesota: 3,125 units · 54.5 per 100k residents MN Wisconsin: 5,478 units · 92.7 per 100k residents WI Michigan: 4,471 units · 44.5 per 100k residents MI New York: 89,228 units · 456 per 100k residents NY Vermont: 355 units · 54.9 per 100k residents VT New Hampshire: 68 units · 4.9 per 100k residents NH Oregon: 393 units · 9.3 per 100k residents OR Nevada: 1,220 units · 38.2 per 100k residents NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: no data reported IL Indiana: 2,600 units · 37.9 per 100k residents IN Ohio: 8,390 units · 71.2 per 100k residents OH Pennsylvania: 13,119 units · 101 per 100k residents PA New Jersey: 2,045 units · 22.0 per 100k residents NJ Massachusetts: no data reported MA California: 33,031 units · 84.8 per 100k residents CA Utah: no data reported UT Colorado: 3,045 units · 51.8 per 100k residents CO Nebraska: 2,525 units · 128 per 100k residents NE Missouri: 5,488 units · 88.6 per 100k residents MO Kentucky: no data reported KY West Virginia: no data reported WV Virginia: 2,185 units · 25.1 per 100k residents VA Maryland: 1,135 units · 18.4 per 100k residents MD Connecticut: 3,028 units · 83.7 per 100k residents CT Rhode Island: 225 units · 20.5 per 100k residents RI Arizona: 1,095 units · 14.7 per 100k residents AZ New Mexico: no data reported NM Kansas: 1,868 units · 63.5 per 100k residents KS Arkansas: no data reported AR Tennessee: 3,473 units · 48.7 per 100k residents TN North Carolina: 3,457 units · 31.9 per 100k residents NC South Carolina: 840 units · 15.6 per 100k residents SC Delaware: 675 units · 65.5 per 100k residents DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: 218 units · 2.0 per 100k residents GA D.C.: 135 units · 19.9 per 100k residents DC Hawaii: no data reported HI Texas: 8,574 units · 28.1 per 100k residents TX Florida: 148 units · 0.7 per 100k residents FL
Units reimbursed · per 100k residents
0.7456
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 New York 456 /100k
2 Nebraska 128 /100k
3 Pennsylvania 101 /100k
4 Wisconsin 92.7 /100k
5 Missouri 88.6 /100k
6 California 84.8 /100k
7 Connecticut 83.7 /100k
8 Ohio 71.2 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.
← 00536-1306-08 · Rugby 00536-1308-40 · Rugby →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.